Compare INDV & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDV | LION |
|---|---|---|
| Founded | N/A | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.1B |
| IPO Year | 2014 | 2025 |
| Metric | INDV | LION |
|---|---|---|
| Price | $39.08 | $11.96 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $11.89 |
| AVG Volume (30 Days) | 2.3M | ★ 2.4M |
| Earning Date | 06-08-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | $1,239,000,000.00 | ★ $2,631,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $22.98 |
| P/E Ratio | $23.43 | ★ N/A |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.22 | $5.88 |
| 52 Week High | $42.81 | $16.70 |
| Indicator | INDV | LION |
|---|---|---|
| Relative Strength Index (RSI) | 49.46 | 29.30 |
| Support Level | $38.47 | $9.11 |
| Resistance Level | $41.83 | $12.58 |
| Average True Range (ATR) | 1.64 | 0.55 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 56.54 | 3.49 |
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.